Hidalgo Ramos Roberto A, Dufner Krieger Sebastián, Ortiz Meneses Marcelo
Medicine, Universidad de Costa Rica, San José, CRI.
Cureus. 2025 Jul 15;17(7):e88000. doi: 10.7759/cureus.88000. eCollection 2025 Jul.
Optical coherence tomography angiography (OCTA) offers a promising approach for detecting subclinical microvascular changes in glaucoma suspects before structural or functional damage becomes apparent. This scoping review synthesizes evidence from 11 studies (2014-2025) to evaluate OCTA's effectiveness in identifying early glaucomatous alterations. Findings consistently demonstrate reduced vessel density (VD) in glaucoma suspects compared to healthy controls, with whole-image VD averaging 51.3% versus 55.5% (P<0.001), respectively. OCTA-derived parameters, particularly peripapillary and macular VD, showed diagnostic accuracy (area under the receiver-operating characteristic curve (AUROC): 0.70-0.84) comparable to structural OCT metrics like retinal nerve fiber layer thickness. Notably, microvascular asymmetry and deep-layer capillary dropout emerged as early markers, often preceding visual field defects. Longitudinal data revealed faster VD decline in preperimetric glaucoma (-2.23%/year) than in healthy eyes (0.29%/year), highlighting OCTA's potential for monitoring progression. Despite methodological heterogeneity, OCTA complements structural assessments, providing actionable insights for early glaucoma detection. Standardization of protocols and longitudinal validation are needed to optimize clinical utility. These findings support OCTA's role in enhancing risk stratification for glaucoma suspects.
光学相干断层扫描血管造影(OCTA)为在青光眼可疑患者出现明显的结构或功能损害之前检测亚临床微血管变化提供了一种很有前景的方法。这项范围综述综合了11项研究(2014 - 2025年)的证据,以评估OCTA在识别早期青光眼改变方面的有效性。研究结果一致表明,与健康对照相比,青光眼可疑患者的血管密度(VD)降低,全图像VD平均分别为51.3%和55.5%(P<0.001)。OCTA得出的参数,特别是视乳头周围和黄斑区的VD,显示出与视网膜神经纤维层厚度等结构OCT指标相当的诊断准确性(受试者操作特征曲线下面积(AUROC):0.70 - 0.84)。值得注意的是,微血管不对称和深层毛细血管缺失成为早期标志物,通常先于视野缺损出现。纵向数据显示,视野检查前青光眼患者的VD下降速度(-2.23%/年)比健康眼睛(0.29%/年)更快,突出了OCTA在监测病情进展方面的潜力。尽管存在方法学上的异质性,但OCTA可补充结构评估,为早期青光眼检测提供可采取行动的见解。需要对方案进行标准化并进行纵向验证,以优化临床应用。这些发现支持了OCTA在加强青光眼可疑患者风险分层方面的作用。